«Identification of Reference Genes for Quantitative RT-PCR in Ascending Aortic Aneurysms»
Dominic Henn, Doris Bandner-Risch, Hilja Perttunen, Wolfram Schmied, Carlos Porras, Francisco Ceballos, Noela Rodriguez-Losada, Hans-Joachim Schäfers
PLoS One. 2013;8(1):e54132. doi: 10.1371/journal.pone.0054132. Epub 2013 Jan 11.
Hypertension and congenital aortic valve malformations are frequent causes of ascending aortic aneurysms. The molecular mechanisms of aneurysm formation under these circumstances are not well understood. Reference genes for gene activity studies in aortic tissue that are not influenced by aortic valve morphology and its hemodynamic consequences, aortic dilatation, hypertension, or antihypertensive medication are not available so far. This study determines genes in ascending aortic tissue that are independent of these parameters.
Tissue specimens from dilated and undilated ascending aortas were obtained from 60 patients (age ≤70 years) with different morphologies of the aortic valve (tricuspid undilated n = 24, dilated n = 11; bicuspid undilated n = 6, dilated n = 15; unicuspid dilated n = 4). Of the studied individuals, 36 had hypertension, and 31 received ACE inhibitors or AT1 receptor antagonists. The specimens were obtained intraoperatively from the wall of the ascending aorta. We analyzed the expression levels of 32 candidate reference genes by quantitative RT-PCR (RT-qPCR). Differential expression levels were assessed by parametric statistics. The expression analysis of these 32 genes by RT-qPCR showed that EIF2B1, ELF1, and PPIA remained constant in their expression levels in the different specimen groups, thus being insensitive to aortic valve morphology, aortic dilatation, hypertension, and medication with ACE inhibitors or AT1 receptor antagonists. Unlike many other commonly used reference genes, the genes EIF2B1, ELF1, and PPIA are neither confounded by aortic comorbidities nor by antihypertensive medication and therefore are most suitable for gene expression analysis of ascending aortic tissue.
At the Andalusian Institute of Cardiotecnology we unite the knowledge of four clinical areas to offer the highest level of cardiological care.
ICTA: the heartbeat of a team
The Arrhythmias Unit of the Heart Area cares for patients with heart rhythm disorders. It is divided into two specific areas.
Read moreICTA has the first Marfan unit set up in the private health sector in Spain: we diagnose, follow-up and treat Marfan syndrome patients.
Read moreModern Cardiac Surgery: coronary surgery with and without extracorporeal circulation, conventional valve surgery, etc.
Our group has pioneered aortic valve replacement techniques. Our operating theatre is fully equipped for aortic root surgeries.
Read moreElectrocardiograms, stress tests & echocardiograms: consultations at Hospital Xanit (Benalmádena) or Fuengirola .
Early diagnosis, follow-up and treatment of potentially lethal cardiovascular diseases that may result in sudden death in athletes.
Read more